DIFFERENTIAL DIAGNOSIS
See Etiology.
TREATMENT
PRE HOSPITAL
Universal precautions, masks if infectious etiology suspected
INITIAL STABILIZATION/THERAPY
Aggressive, presumptive management of potentially lethal presentations:
- Petechial lesions
- Disseminated erythematous or vesicobullous lesions
- Purpura with systemic symptoms
- Erythroderma with systemic symptoms
ED TREATMENT/PROCEDURES
- Treatment directed by underlying cause
- Immediate empiric antibiotics targeted toward meningococcemia and RMSF in unstable patients with fever and purpura
- Treat disseminated bullous or exfoliative disease as a severe thermal burn.
- Symptomatic treatment of pruritus (diphenhydramine or hydroxyzine)
- Steroid therapy reserved for clear allergic reactions, relapse of known steroid responsive disease, or in consultation with dermatologist
- Allergic reactions:
- H
1
-blocker
- H
2
-blocker
- Steroids
- Epinephrine if respiratory compromise
MEDICATION
- Prednisone: 1 mg/kg (max. 60 mg/d)
- Diphenhydramine: 25–50 mg PO/IM/IV q6h
- Hydroxyzine: 25–100 mg PO q6h
- Methylprednisolone: 125 mg IV q24h
- Topical steroids: Classes 3–5 depending on location and severity
FOLLOW-UP
DISPOSITION
Admission Criteria
- Patients with significant bullous/exfoliative disorders
- Associated systemic symptoms
Discharge Criteria
- Limited lesions
- Viral exanthems
- Absence of systemic signs or symptoms
- Stable, chronic presentation
Issues for Referral
Discharge to follow up with primary care physician or dermatologist
FOLLOW-UP RECOMMENDATIONS
- Reassure patients that rashes that cannot be diagnosed in the ED are often due to a mild viral illnesses or allergic reactions
- Stress the importance, however, of a follow-up visit with their physician or a dermatologist to obtain the best possible outcome.
- The patient should see his doctor quickly or return to the ED if the condition worsens:
- Spreading redness from the rash
- Increasing pain from the rash
- Joint pain
- Spreading of the rash with crusting
- Fever
- Severe headache
- Confusion
- Signs of a life-threatening allergic reaction:
- Feeling dizzy or faint
- Trouble breathing or swallowing
- Swelling of the tongue
PEARLS AND PITFALLS
- Rapid evolution of a rash with systemic symptoms can indicate a dermatologic emergency
- Treat rapidly with empiric antibiotics in patients with purpura and fever to cover for meningococcemia and RMSF.
- Treat rapidly with empiric antibiotics in patients with erythroderma, fever, and hypotension to cover toxic shock syndrome.
- Hyperpigmented scaly papules on the palms and soles require that secondary syphilis be ruled out.
ADDITIONAL READING
- Brady WJ, DeBehnke D, Crosby DL. Dermatological emergencies.
Am J Emerg Med
. 1994;12(2):217–237.
- Browne BJ, Edwards B, Rogers RL. Dermatologic emergencies.
Prim Care
. 2006;33(3):685–695, vi.
- Freiman A, Borsuk D, Sasseville D. Dermatologic emergencies.
CMAJ
. 2005;173(11):1317–1319.
- Gropper CA. An approach to clinical dermatologic diagnosis based on morphologic reaction patterns.
Clin Cornerstone
. 2001;4(1):1–14.
- Usatine RP, Sandy N. Dermatologic emergencies.
Am Fam Physician.
2010;82(7):773–780.
See Also (Topic, Algorithm, Electronic Media Element)
Purpura
CODES
ICD9
782.1 Rash and other nonspecific skin eruption
ICD10
R21 Rash and other nonspecific skin eruption
RASH, PEDIATRIC
Bruce Webster
BASICS
DESCRIPTION
- Lesion morphology:
- Macule:
- Localized nonpalpable changes in skin color
- Purpura or petechiae (nonblanching with pressure)
- Maculopapule:
- Slightly elevated lesions with localized changes in skin
- Papule:
- Solid, elevated lesions <5 mm in diameter
- Keratotic (rough-surfaced lesion)
- Nonkeratotic (smooth lesion)
- Palpable purpura (nonblanching with pressure)
- Plaque:
- Solid, elevated lesions >5 mm in diameter
- Often results from a confluence of papules
- Nodule:
- Solid, elevated lesions extending deep into the dermis or SC tissue >5 mm in diameter
- Wheal:
- Circular, irregular lesions varying from red to pale
- Vesicle:
- Clear, fluid-filled lesions <5 mm in diameter
- Bullae:
- Clear, fluid-filled lesions >5 mm in diameter
- Pustules:
- Secondary lesions:
- Scales:
- Thin plates of dried cornified epithelium partially separated from the epidermis
- Lichenification:
- Dried plaques resulting in skin furrowing
- Erosion:
- Moist surface uncovered by rupture of vesicles or bullae
- Excoriation:
- Linear loss of the skin due to trauma
- Ulcer:
- Deep loss of the skin involving the epidermis and a variable amount of the dermis and SC tissue
- Configuration:
- Circles or arcs
- Serpiginous (creeping or worm like)
- Iris grouping (bull’s eye appearance)
- Irregular grouping
- Zosteriform grouping
- Linear grouping
- Retiform grouping
- The color of a lesion or the entire skin may be due to a number of substances:
- Red or red-brown lesions result from oxyhemoglobin found in RBCs.
- The macular erythematous lesions seen in viral exanthema usually represent dilated superficial cutaneous vessels.
- Purpura and petechiae result from leakage of RBCs out of the vascular space.
- Hypopigmentation or hyperpigmentation represent postinflammatory change from either increases or decreases in melanin production.
- Depigmentation refers to the total loss of pigment secondary to autoimmune effect (vitiligo) or congenital disorders (albinism).
- Scales represent a proliferative disorder of epidermal cell turnover.
ETIOLOGY
- Papulosquamous:
- Infections:
- Viral or bacterial
- Rickettsial or fungal
- Allergic reactions
- Autoimmune disorders
- Purpura and petechiae:
- Clotting or platelet disorder
- Vascular fragility disease
- Vasculitis
- Overwhelming infection
- Vesicobullous:
- Infection
- Drug reaction
- Autoimmune disorder
- Ulcer:
- Infection
- Vascular insufficiency
DIAGNOSIS